Cardiovascular secondary prevention in high-risk patients: A randomized controlled trial sub-study

BMC Cardiovascular Disorders

Volumn 15, Issue 1, 2015, Pages

  Jakobsson, Stina ^a   Irewall, Anna Lotta ^a   Bjorklund, Fredrik ^a   Mooe, Thomas ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Acute coronary syndrome; Cardiovascular disease; Chronic renal insufficiency; Diabetes mellitus; Myocardial infarction; Secondary prevention; Stroke; Transient ischemic attack

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIHYPERTENSIVE AGENT;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENERAL PRACTITIONER; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SECONDARY PREVENTION; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; UNSTABLE ANGINA PECTORIS; VERY ELDERLY; BLOOD; CHRONIC KIDNEY FAILURE; COMPLICATION; DIABETIC ANGIOPATHY; ISCHEMIC ATTACK, TRANSIENT; NURSING; PROCEDURES; RECURRENT DISEASE; STROKE; TELEPHONE;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CHOLESTEROL, LDL; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; RECURRENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SECONDARY PREVENTION; STROKE; TELEPHONE;

EID: 84944384967     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-015-0115-0     Document Type: Article

References (22)

1. Dhamoon MS, Tai W, Boden-Albala B, Rundek T, Paik MC, Sacco RL, et al. Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan study. Stroke. 2007;38(6):1752-8. doi: 10.1161/STROKEAHA.106.480988.
2. SWEDEHEART Annual report 2014. http://www.ucr.uu.se/swedeheart/index.php/dokument-sh/arsrapporter. 2015.
3. Ulvenstam A, Kajermo U, Modica A, Jernberg T, Soderstrom L, Mooe T. Incidence, trends, and predictors of ischemic stroke 1 year after an acute myocardial infarction. Stroke. 2014;45(11):3263-8. doi: 10.1161/STROKEAHA.114.005770.
4. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33(13):1635-701. doi: 10.1093/eurheartj/ehs092.
5. Alvarez-Sabin J, Quintana M, Hernandez-Presa MA, Alvarez C, Chaves J, Ribo M. Therapeutic interventions and success in risk factor control for secondary prevention of stroke. J Stroke Cerebrovasc Dis. 2009;18(6):460-5. doi: 10.1016/j.jstrokecerebrovasdis.2009.01.014.
6. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295(2):180-9. doi: 10.1001/jama.295.2.180.
7. Kotseva K, Wood D, De Bacquer D, De Backer G, Ryden L, Jennings C et al. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2015. doi: 10.1177/2047487315569401.
8. Buckley BS, Byrne MC, Smith SM. Service organisation for the secondary prevention of ischaemic heart disease in primary care. Cochrane Database Syst Rev. 2010;3:CD006772. doi: 10.1002/14651858.CD006772.pub2.
9. Lager KE, Mistri AK, Khunti K, Haunton VJ, Sett AK, Wilson AD. Interventions for improving modifiable risk factor control in the secondary prevention of stroke. Cochrane Database Syst Rev. 2014;5:CD009103. doi: 10.1002/14651858.CD009103.pub2.
10. Neubeck L, Redfern J, Fernandez R, Briffa T, Bauman A, Freedman SB. Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review. Eur J Cardiovasc Prev Rehabil. 2009;16(3):281-9. doi: 10.1097/HJR.0b013e32832a4e7a.
11. Arnett DK, Goodman RA, Halperin JL, Anderson JL, Parekh AK, Zoghbi WA. AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and US Department of Health and Human Services. Circulation. 2014;130(18):1662-7. doi: 10.1161/CIR.0000000000000128.
12. Donahoe SM, Stewart GC, McCabe CH, Mohanavelu S, Murphy SA, Cannon CP, et al. Diabetes and mortality following acute coronary syndromes. JAMA. 2007;298(7):765-75. doi: 10.1001/jama.298.7.765.
13. Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B, Griffith JL, et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis. 2004;44(2):198-206.
14. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
15. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31-40. doi: 10.1016/S0140-6736(11)60679-X.
16. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260-72. doi: 10.1016/S0140-6736(13)60687-X.
17. Mooe T, Bergstrom L, Irewall AL, Ogren J. The NAILED stroke risk factor trial (nurse based age independent intervention to limit evolution of disease after stroke): study protocol for a randomized controlled trial. Trials. 2013;14:5. doi: 10.1186/1745-6215-14-5.
18. Mooe T, Bjorklund F, Graipe A, Huber D, Jakobsson S, Kajermo U, et al. The Nurse-Based Age Independent Intervention to Limit Evolution of Disease After Acute Coronary Syndrome (NAILED ACS) risk factor trial: protocol for a randomized controlled trial. JMIR Res Protoc. 2014;3(3):e42. doi: 10.2196/resprot.3466.
19. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro 3rd AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12.
20. National KF. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266.
21. McAlister FA, Majumdar SR, Padwal RS, Fradette M, Thompson A, Buck B, et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. CMAJ. 2014;186(8):577-84. doi: 10.1503/cmaj.140053.
22. Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GF. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012;157(4):263-75. doi: 10.7326/0003-4819-157-4-201208210-00007.